QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2022    专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 An Implantable Magnetic Vascular Scaffold for Circulating Tumor Cell Removal In Vivo 期刊论文 ADVANCED MATERIALS, 2022 作者:  Yin, Zhiwei;  Shi, Rui;  Xia, Xin;  Li, Ling;  Yang, Yanxia 收藏  |  浏览/下载：23/0  |  提交时间：2022/12/23 adhesion repertoires  bioinspired ultrastructure  circulating tumor cell removal  magnetothermal response  vascular-like integrated trapped devices   Zirconium telluride saturable absorber for Er:YAP dual-wavelength ultrafast laser at 3 mu m 期刊论文 OPTICS AND LASER TECHNOLOGY, 2022, 卷号: 155 作者:  Cai, Enlin;  Xu, Jianyi;  Xia, Yuanying;  Hao, Linhong;  Zhang, Qingyue 收藏  |  浏览/下载：16/0  |  提交时间：2022/12/22 Mid-infrared laser  Passively mode-locked  2D materials   Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements 期刊论文 LIVER CANCER, 2022, 卷号: 11 作者:  Sun, Yongkun;  Zhang, Wen;  Bi, Xinyu;  Yang, Zhengqiang;  Tang, Yu 收藏  |  浏览/下载：34/0  |  提交时间：2022/12/23 Chinese interdisciplinary experts  Hepatocellular carcinoma  Molecular targeted therapy  Consensus   Maintenance endocrine therapy prolonged progression-free survival of first-line chemotherapy with trastuzumab in advanced HR-positive, HER2-positive breast cancer patients. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Shen, Xia-Bo;  Wu, Jia-Yi;  Chen, Ke-Yu;  Fang, Zi-Ru;  Li, Guang-Liang 收藏  |  浏览/下载：14/0  |  提交时间：2022/12/23 Platelet-to-Lymphocyte ratio (PLR) as a predictive marker in HER2 positive metastatic breast cancer patients treated with first-line trastuzumab therapy. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Fang, Zi-Ru;  Shen, Xia-Bo;  Wu, Jia-Yi;  Chen, Ke-Yu;  Shao, Xi-Ying 收藏  |  浏览/下载：10/0  |  提交时间：2022/12/23